335060
SAMHSA Suicide Prevention Initiatives and the Suicide SAFE Mobile Application
This presentation provides an overview of current suicide prevention initiatives at SAMHSA, with particular emphasis on the development and functional utility of the SAMHSA Suicide SAFE Mobile App.
The session uses the example of the development a mobile app - SAMHSA's "Suicide SAFE"- to improve suicide assessment approaches among behavioral health and primary care clinicians. The panelists have all been involved in various aspects of the app development.The panel discussion exploring how the perspective of the client/patient may be kept central to the development and creation of a digital solution that supports best practices in the assessment, diagnosis, and treatment of behavioral health concerns.
Learning Areas:
Chronic disease management and preventionCommunication and informatics
Diversity and culture
Other professions or practice related to public health
Planning of health education strategies, interventions, and programs
Public health or related education
Learning Objectives:
Identify current initiatives in suicide prevention at the Substance Abuse and Mental Health Services Administration (SAMHSA).
Describe how the Suicide SAFE mobile app provide support to the clinician working with a person in potential or current suicidal crisis.
Keyword(s): Suicide, Communication Technology
Qualified on the content I am responsible for because: I currently serve as Chief for the Suicide Prevention Branch at the Substance Abuse and Mental Health Services Administration (SAMHSA). Previously, I established New Jerseyâs first evidenced based treatment program for chronically suicidal borderline, and worked as a Congressional Fellow in mental health policy for Senator Paul Wellstone. I have served on the Board of the American Psychological Association, as well as Clinical Division Director for the American Association of Suicidology.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.